Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

References for PMC Articles for PubMed (Select 23112894)

1.

Premarital screening test results for β-thalassemia and sickle cell anemia trait in east Mediterranean region of Turkey.

Guler E, Garipardic M, Dalkiran T, Davutoglu M.

Pediatr Hematol Oncol. 2010 Nov;27(8):608-13. doi: 10.3109/08880018.2010.503772.

PMID:
20795773
2.

Causes for hospitalization and death in Iranian patients with β-thalassemia major.

Bazrgar M, Peiravian F, Abedpour F, Karimi M.

Pediatr Hematol Oncol. 2011 Mar;28(2):134-9. doi: 10.3109/08880018.2010.503336. Epub 2010 Aug 26.

PMID:
20795770
3.

The survival analysis of beta thalassemia major patients in South East of Iran.

Roudbari M, Soltani-Rad M, Roudbari S.

Saudi Med J. 2008 Jul;29(7):1031-5.

PMID:
18626536
4.

Survival of thalassemic patients referred to the Boo Ali Sina Teaching Hospital, Sari, Iran.

Kosaryan M, Vahidshahi K, Karami H, Forootan MA, Ahangari M.

Hemoglobin. 2007;31(4):453-62.

PMID:
17994379
5.

The experience of beta-thalassaemia and its prevention in Cyprus.

Kalokairinou EM.

Med Law. 2007 Jun;26(2):291-307. Corrected and republished in: Med Law. 2008 Dec;27(4):825-41.

PMID:
17639852
6.

Premarital screening for thalassemia and sickle cell disease in Saudi Arabia.

Alhamdan NA, Almazrou YY, Alswaidi FM, Choudhry AJ.

Genet Med. 2007 Jun;9(6):372-7.

PMID:
17575503
7.

Evaluation of the national health policy of thalassaemia screening in the Islamic Republic of Iran.

Ghotbi N, Tsukatani T.

East Mediterr Health J. 2005 May;11(3):308-18.

PMID:
16602449
8.

Cost-effectiveness of prenatal screening for thalassaemia in Hong Kong.

Leung KY, Lee CP, Tang MH, Lau ET, Ng LK, Lee YP, Chan HY, Ma ES, Chan V.

Prenat Diagn. 2004 Nov;24(11):899-907.

PMID:
15565640
9.

Iranian national thalassaemia screening programme.

Samavat A, Modell B.

BMJ. 2004 Nov 13;329(7475):1134-7. No abstract available.

10.

The beta-thalassemia mutation spectrum in the Iranian population.

Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, Amirizadeh N, Karimi-Nejad MH.

Hemoglobin. 2001 Aug;25(3):285-96.

PMID:
11570721
11.

[Prenatal diagnosis of beta-thalassemia. A study based in Calabria].

Morelli M, Zullo F, Noia R, Corea D, Arduino B, Piccione F, Mastrantonio P.

Minerva Ginecol. 2001 Aug;53(4):251-5. Italian.

PMID:
11431641
12.

Premarital screening of beta-thalassemia trait in the province of Denizli, Turkey.

Keskin A, Türk T, Polat A, Koyuncu H, Saracoglu B.

Acta Haematol. 2000;104(1):31-3.

PMID:
11111119
13.

Lifetime treatment costs of beta-thalassaemia major.

Karnon J, Zeuner D, Brown J, Ades AE, Wonke B, Modell B.

Clin Lab Haematol. 1999 Dec;21(6):377-85.

PMID:
10671989
14.

Molecular diagnosis and carrier screening for beta thalassemia.

Cao A, Saba L, Galanello R, Rosatelli MC.

JAMA. 1997 Oct 15;278(15):1273-7.

PMID:
9333270
15.

Control of homozygous beta-thalassemia by carrier screening and antenatal diagnosis in Sardinia.

Cao A, Furbetta M, Galanello R, Melis MA, Angius A, Rosatelli C, Ruggeri R, Addis M, Tuveri T, Falchi AM, Maccioni L, Paglietti E, Scalas MT.

Birth Defects Orig Artic Ser. 1982;18(7):303-11. No abstract available.

PMID:
7159738
16.

Cost-benefit analysis of a thalassemia disease prevention program.

Ostrowsky JT, Lippman A, Scriver CR.

Am J Public Health. 1985 Jul;75(7):732-6.

17.

Antenatal diagnosis of beta-thalassemia in Sardinia.

Cao A, Rosatelli MC, Leoni GB, Tuveri T, Scalas MT, Monni G, Olla G, Galanello R.

Ann N Y Acad Sci. 1990;612:215-25. Review.

PMID:
2291548
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk